Asher Mullard. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Clinical Trials, Phase II as TopicDrug Industry/trendsHumansMembrane Proteins/drug effectsMultiple Sclerosis/drug therapyMultiple Sclerosis/physiopathologyMyelin Sheath/drug effectsMyelin Sheath/physiologyNerve RegenerationNerve Tissue Proteins/drug effects
Substances: See more » LINGO1 protein, humanMembrane ProteinsNerve Tissue Proteins
Year: 2016 PMID: 27469222 DOI: 10.1038/nrd.2016.158
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN: 1474-1776 Impact factor: 84.694